Paroxysmal Nocturnal Hemoglobinuria (PNH)

DBCOND0028737Cardiovascular DiseasesHemic and Lymphatic Diseases

Paroxysmal Nocturnal Hemoglobinuria (PNH) is the indication for 6 drugs in DrugBank. It is covered by 14 curated, structured indications.

Also known as
Paroxysmal Nocturnal Hemoglobinuria · Paroxysmal Nocturnal Haemoglobinuria · PNH · Paroxysmal Nocturnal Haemoglobinuria (PNH) · Marchiafava-Micheli Syndrome
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0010137ICD-10D59.5SNOMED CT154805009MedDRA10034042UMLSC0024790

What you can answer from here — as of October 22, 2026

6Indicated drugsWith each drug's targets and mechanism
Listed above
14Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
147Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Paroxysmal Nocturnal Hemoglobinuria (PNH) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In